RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Free Cash Flow came in at -$109213.0 in Q1 2026, up 41.67% year-on-year from -$77091.6 in Q1 2025, and up 14.82% quarter-over-quarter from -$128219.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Free Cash Flow across 7 years of filings, most recently posting -$109213.0 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$109213.0, up 41.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$480341.0 (up 37.24% YoY), and the FY2025 annual result was -$558350.0, up 24.74% from the prior year.
- Free Cash Flow came in at -$109213.0 for Q1 2026 at RetinalGenix Technologies, up from -$128219.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $39749.0 in Q3 2023 to a low of -$290025.0 in Q4 2023.
- The 5-year median for Free Cash Flow is -$123810.0 (2023), against an average of -$121202.8.
- Peak annual rise in Free Cash Flow reached 167.42% in 2023, while the deepest fall reached 1100.41% in 2023.
- RetinalGenix Technologies' Free Cash Flow stood at -$33225.0 in 2022, then plunged by 772.91% to -$290025.0 in 2023, then jumped by 35.73% to -$186390.0 in 2024, then soared by 31.21% to -$128219.0 in 2025, then climbed by 14.82% to -$109213.0 in 2026.
- The last three Free Cash Flow figures came in at -$109213.0 (Q1 2026), -$128219.0 (Q4 2025), and -$103837.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |